Russell Investments Group
OLMA icon

Russell Investments Group’s Olema Pharmaceuticals OLMA Stock Holding History

Russell Investments Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$523K Buy
41,808
+35,229
+535% +$472K ﹤0.01% 2754
2026
Q1 		$98.1K Buy
6,579
+1,844
+39% +$41K ﹤0.01% 3092
2025
Q4 		$118K Sell
4,735
-664
-12% -$11.8K ﹤0.01% 3002
2025
Q3 		$52.9K Buy
+5,399
New +$32.4K ﹤0.01% 3268
2024
Q3 		– Sell
-1,018
Closed -$11K – 3763
2024
Q2 		$11K Buy
1,018
+981
+2,651% +$10.6K ﹤0.01% 3052
2024
Q1 		$419 Buy
+37
New +$477 ﹤0.01% 3229
2023
Q1 		– Sell
-11,991
Closed -$29.4K – 3355
2022
Q4 		$29.4K Sell
11,991
-9,597
-44% -$28K ﹤0.01% 2775
2022
Q3 		$59K Buy
+21,588
New +$91.6K ﹤0.01% 2730
2021
Q4 		– Sell
-125,383
Closed -$3.46M – 3075
2021
Q3 		$3.46M Buy
+125,383
New +$3.38M 0.01% 1474

Other funds holding OLMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Russell Investments Group's OLMA Position: Q2 2026 in Review

Russell Investments Group increased its Olema Pharmaceuticals (OLMA) stake by 535% in Q2 2026, buying an estimated $472K and bringing the position to 41,808 shares worth $523K. The position accounts for ﹤0.01% of the portfolio, ranked #2754.

Russell Investments Group first reported a position in OLMA in Q3 2021 and has held it in 9 quarters since. The position peaked at $3.46M in Q3 2021. 50 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Russell Investments Group held 41,808 shares of Olema Pharmaceuticals worth $523K as of Q2 2026.
  • Russell Investments Group bought 35,229 Olema Pharmaceuticals shares in Q2 2026, an estimated $472K.
  • Olema Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2754 holding.
  • Russell Investments Group first reported a position in Olema Pharmaceuticals in Q3 2021 and has held it in 9 quarters since.
  • Russell Investments Group's Olema Pharmaceuticals position peaked at $3.46M in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.